Michael Hearne

Michael Hearne

Director of Finance/CFO at ODONATE, INC.

Net worth: 2 M $ as of 30/09/2026

64 year
Health Technology
Commercial Services
Consumer Services

Profile

Mr. Michael S.
Hearne
, CPA, is a Chief Financial Officer at Tang Capital Acquisition Corp., a Chief Financial Officer at Kezar Life Sciences, Inc., a Chief Financial Officer at Aurinia Pharmaceuticals, Inc. and a Chief Financial Officer at Odonate, Inc. Mr. Hearne was previously employed as a Chief Financial Officer & Secretary by La Jolla Pharmaceutical Co., a Partner by Weaver & Tidwell LLP, a Managing Director & Principal by Carson Private Capital, Inc., and a Partner by Rothstein, Kass & Co. LLC.
He received his undergraduate degree from Brigham Young University, an undergraduate degree from Texas A&M University and a graduate degree from Brigham Young University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/05/2026 116,144 ( 0.09% ) 2 M $ 30/09/2026

Michael Hearne active positions

CompaniesPositionStart
ODONATE, INC. Director of Finance/CFO 19/11/2018
AURINIA PHARMACEUTICALS INC. Director of Finance/CFO 23/03/2026
KEZAR LIFE SCIENCES, INC. Director of Finance/CFO 11/05/2026

Former positions of Michael Hearne

CompaniesPositionEnd
Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal 01/01/2008
LA JOLLA PHARMACEUTICAL COMPANY Director of Finance/CFO -
Private Equity Investor -
See the detail of Michael Hearne's experience

Education of Michael Hearne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Hearne